Correlation Between Vor Biopharma and Nuvation Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Nuvation Bio, you can compare the effects of market volatilities on Vor Biopharma and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Nuvation Bio.

Diversification Opportunities for Vor Biopharma and Nuvation Bio

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vor and Nuvation is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Nuvation Bio go up and down completely randomly.

Pair Corralation between Vor Biopharma and Nuvation Bio

Considering the 90-day investment horizon Vor Biopharma is expected to generate 1.61 times more return on investment than Nuvation Bio. However, Vor Biopharma is 1.61 times more volatile than Nuvation Bio. It trades about 0.06 of its potential returns per unit of risk. Nuvation Bio is currently generating about 0.01 per unit of risk. If you would invest  117.00  in Vor Biopharma on October 13, 2024 and sell it today you would earn a total of  38.50  from holding Vor Biopharma or generate 32.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.31%
ValuesDaily Returns

Vor Biopharma  vs.  Nuvation Bio

 Performance 
       Timeline  
Vor Biopharma 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Vor Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.
Nuvation Bio 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvation Bio are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nuvation Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Vor Biopharma and Nuvation Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vor Biopharma and Nuvation Bio

The main advantage of trading using opposite Vor Biopharma and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.
The idea behind Vor Biopharma and Nuvation Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum